0078-0654 : Jadenu 90 mg Oral Tablet, Film Coated


NDC0078-0654
Labeler: Novartis Pharmaceuticals Corporation
Product Type: Human Prescription Drug
Drug Name:  Jadenu
Dosage Form: Oral Tablet, Film Coated
Application #: NDA206910
Rev. Date: 


Appearance:


Markings: NVR;90
Shapes:  Oval
Colors:  Blue
Size (mm): 11
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

NDC Package Codes:

  • 0078-0654-15: 30 TABLET, FILM COATED IN 1 BOTTLE (0078‑0654‑15)

Active Ingredients:

  • Deferasirox

Dosage Strength:

  • 90 mg

Inactive Ingredients:

  • Cellulose, Microcrystalline
  • Crospovidone
  • Povidone K30
  • Magnesium Stearate
  • Silicon Dioxide
  • Poloxamer 188

Pharmaceutical Classes:

  • Cytochrome P450 1A2 Inhibitors [MoA]
  • Cytochrome P450 2C8 Inhibitors [MoA]
  • Cytochrome P450 3A4 Inducers [MoA]
  • Iron Chelating Activity [MoA]
  • Iron Chelator [EPC]

Related Products:

Based on records with the same trade name.
  • 0078-0655 Jadenu 180 mg Oral Tablet, Film Coated by Novartis Pharmaceuticals Corporation
  • 0078-0656 Jadenu 360 mg Oral Tablet, Film Coated by Novartis Pharmaceuticals Corporation
  • 0078-0713 Jadenu 180 mg Oral Granule by Novartis Pharmaceuticals Corporation
  • 0078-0720 Jadenu 360 mg Oral Granule by Novartis Pharmaceuticals Corporation
  • 0078-0727 Jadenu 90 mg Oral Granule by Novartis Pharmaceuticals Corporation

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0078-0654 QR Code

< Prev: 0078-0652Next: 0078-0655 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.